Jasenka Piljac Žegarac, PhD

Jasenka is a scientist and professional freelance medical writer with expertise in a wide range of therapeutic and scientific areas. Her research articles have gathered more than 1200 citations. At The Scientist Writer LLC, she helps clients from the food, pharma, and biotech industries develop top-quality communications solutions. Find Jasenka on LinkedIn.

Most Recent Articles by Jasenka Piljac Žegarac, PhD

Overcoming Challenges to Create a Universal Influenza Vaccine

Overcoming Challenges to Create a Universal Influenza Vaccine

By

Researchers from the National Institute of Allergy and Infectious Diseases are working to develop a universal influenza vaccine.

Safety, Efficacy of Treprostinil Delivery System for PAH Examined

Safety, Efficacy of Treprostinil Delivery System for PAH Examined

By

Researchers were able to successfully use a fully implantable delivery system for treprostinil for adult patients with pulmonary arterial hypertension.

Lumacaftor/Ivacaftor Safe, Effective for Pediatric Cystic Fibrosis

Lumacaftor/Ivacaftor Safe, Effective for Pediatric Cystic Fibrosis

By

Combination lumacaftor/ivacaftor therapy was found to be safe and effective in patients with cystic fibrosis aged 6 to 11 years.

Morbidity, Mortality in VZV-Related Community-Acquired Pneumonia

Morbidity, Mortality in VZV-Related Community-Acquired Pneumonia

By

A large cohort study of critically ill patients with varicella-zoster virus-related community-acquired pneumonia found that significant morbidity and mortality are associated with the disease.

ACE Inhibitors, ARBs Slow Progression of Emphysema

ACE Inhibitors, ARBs Slow Progression of Emphysema

By

Treatment with full-dose angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers was found to slow disease progression in patients with emphysema.

More Articles by Jasenka Piljac Žegarac, PhD

Sign Up for Free e-newsletters